ArticleVaccines2021

Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns.

Matteo Nioi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.